we had a low of $5.99 last year after attaining a high of $19+ anything is possible, we could wake up one day to partnership news, or see scrips continue to climb who knows, but at 1.2B valuation there is still risk right now, but thats when you make the money after the risk is gone the money has been made, long or short, GL
Jefferson.... You're right on... At a 1.2 billion market cap there is "still risk" right now even at $8. A NCE denial would move the stock downwards at least on the news (and vice versa up on approval) teomporarily.
BUT the big saga is the on-going evolving script and sales figures and those will be watched very closely by
the big boys both to take, extend, or exit , long or short positions. I think the market will give us six months of early data to kind of get untracked in the sales launch, and work out the kinks and the early promotions and their affects on the bottom line.
But for a full year I surely hope our sales are in excess of 100 million or this could be tough sledding.
We should get some glimpse of what is going on with comments following the C conference from analysts who do follow the stock. Fingers crossed.